However, variable expression of E-cadherin in human pancreatic cancer samples and commercial cell lines has been confirmed in several studies, supporting the hypothesis that PDAC cells exhibit a hybrid EMT-related phenotype [38]. This evidence concerns the gene CDH1 and pancreatic neoplasm.